<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CSN5/JAB1 is a critical subunit of the COP9 signalosome (CSN) and is overexpressed in many human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, but little is known about the role of CSN5 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>To explore the functional role of CSN5 in colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, we applied siRNA technology to silence CSN5 in HeLa, SW480, HCT116, HT29, and CaCo2 cells </plain></SENT>
<SENT sid="2" pm="."><plain>CSN5 knock-down led to reduced β-catenin and phospho-bcatenin levels and this was paralleled by reduced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell proliferation and <z:mp ids='MP_0006043'>reduced apoptosis</z:mp> rates, whereas the short-term β-catenin protein stability was enhanced by CSN5 knock-down in SW480 cells </plain></SENT>
<SENT sid="3" pm="."><plain>Together, these data implicate the CSN in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> via regulation of the Wnt/β-catenin pathway </plain></SENT>
</text></document>